|
Association Studies of Thrombosis Genes in Ischemic and Carotid Atherosclerosis |
||||
| Gene |
Reference |
Polymorphism |
Cases, n; controls, n |
Results |
|
|
||||
| Factor V |
Catto et al., 1995 [56]; Catto et al., 1996 [57] |
G1691A |
348; 247 |
Negative |
| Kontula et al., 1995 [58] |
G1691A |
236; 137 |
Negative |
|
| Ridker et al., 1995 [15] |
G1691A |
209; 209 |
Negative |
|
| Martinelli et al., 1997 [59] |
G1691A |
155; 155 |
Negative |
|
| Press et al., 1996 [60] |
G1691A |
116; 54/161/287 |
Negative |
|
| van der Bom et al., 1996 [61] |
G1691A |
112; 222 |
Negative |
|
| Longstreth et al., 1998 [62] |
G1691A |
106; 391 |
Negative |
|
| Halbmayer et al., 1997 [63] |
G1691A |
229; 71 |
Negative |
|
| Markus et al., 1996 [64] |
G1691A |
180; 80 |
Negative |
|
| Factor VII |
Nishiuma et al., 1997 [65] |
R353Q |
137; 83/87 |
Negative |
| Heywood et al., 1997 [66] |
R353Q |
286; 198 |
Negative |
|
| Corral et al., 1998 [67] |
R353Q/323A2 |
104; 104 |
Negative |
|
| Factor XIII |
Catto et al., 1998 [68] |
Val34Leu |
529; 437 |
Negative |
| β-Fibrinogen |
Schmidt et al., 1998 [11] |
C148T |
399 |
Positive |
| Carter et al., 1997 [12] |
G448A |
305; 197 |
Positive |
|
| Kessler et al., 1997 [10] |
G455A |
227; 225 |
Positive |
|
| GPIa/IIa |
Carlsson et al., 1999 [13] |
C807T |
227; 170 |
Positive |
| Carlsson et al., 1997 [69] |
HPA-5 |
218; 165/321 |
Negative |
|
| GPIbα |
Gonzalez-Conejero et al., 1998 [14] |
VNTR |
104; 104 |
Positive |
| HPA-2 |
104; 104 |
Positive |
||
| GPIIb/IIIa |
Carter et al., 1998 [16] |
P1A2 |
505; 402 |
Positive |
| Ridker et al., 1997 [70] |
P1A2 |
209; 209 |
Negative |
|
| Carlsson et al., 1997 [69] |
HPA-1 |
218; 165/321 |
Negative |
|
| HPA-3 |
218; 165/321 |
Negative |
||
| PAI 1 |
Catto et al., 1997 [71] |
4G/5G |
421; 172 |
Negative |
| Prothrombin |
Longstreth et al., 1998 [62] |
G20210A |
106; 391 |
Negative |
| Poort et al., 1996 [72] |
G20210A |
104; 104 |
Negative |
|
| Martinelli et al., 1997 [59] |
G20210A |
155; 155 |
Negative |
|
| Ridker et al., 1999 [73] |
G20210A |
259; 1,744 |
Negative |
|
|
GP, glycoprotein; PAI, plasminogen activator inhibitor. | ||||
Meschia et al. BMC Neurology 2003 3:4 doi:10.1186/1471-2377-3-4 |
||||